These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27250673)

  • 21.
    Sharifnia Z; Bandehpour M; Hamishehkar H; Mosaffa N; Kazemi B; Zarghami N
    Iran J Pharm Res; 2019; 18(4):1659-1675. PubMed ID: 32184837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic mRNAs for manipulating cellular phenotypes: an overview.
    Quabius ES; Krupp G
    N Biotechnol; 2015 Jan; 32(1):229-35. PubMed ID: 24816460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unifying in vitro and in vivo IVT mRNA expression discrepancies in skeletal muscle via mechanotransduction.
    Bhosle SM; Loomis KH; Kirschman JL; Blanchard EL; Vanover DA; Zurla C; Habrant D; Edwards D; Baumhof P; Pitard B; Santangelo PJ
    Biomaterials; 2018 Mar; 159():189-203. PubMed ID: 29331806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gata4 blocks somatic cell reprogramming by directly repressing Nanog.
    Serrano F; Calatayud CF; Blazquez M; Torres J; Castell JV; Bort R
    Stem Cells; 2013 Jan; 31(1):71-82. PubMed ID: 23132827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell fate conversion by mRNA.
    Li M; Sancho-Martinez I; Izpisua Belmonte JC
    Stem Cell Res Ther; 2011 Feb; 2(1):5. PubMed ID: 21345255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineering cell fate: Spotlight on cell-activation and signaling-directed lineage conversion.
    Ebrahimi B
    Tissue Cell; 2016 Oct; 48(5):475-87. PubMed ID: 27514850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of human induced pluripotent stem cells using non-synthetic mRNA.
    Rohani L; Fabian C; Holland H; Naaldijk Y; Dressel R; Löffler-Wirth H; Binder H; Arnold A; Stolzing A
    Stem Cell Res; 2016 May; 16(3):662-72. PubMed ID: 27064648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells with Sleeping Beauty Transposon-Based Stable Gene Delivery.
    Sebe A; Ivics Z
    Methods Mol Biol; 2016; 1400():419-27. PubMed ID: 26895068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA-Generated and Gene-Edited Induced Pluripotent Stem Cells for Disease Modeling and Therapy.
    Kehler J; Greco M; Martino V; Pachiappan M; Yokoe H; Chen A; Yang M; Auerbach J; Jessee J; Gotte M; Milanesi L; Albertini A; Bellipanni G; Zucchi I; Reinbold RA; Giordano A
    J Cell Physiol; 2017 Jun; 232(6):1262-1269. PubMed ID: 27631155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro synthesis of modified mRNA for induction of protein expression in human cells.
    Avci-Adali M; Behring A; Steinle H; Keller T; Krajeweski S; Schlensak C; Wendel HP
    J Vis Exp; 2014 Nov; (93):e51943. PubMed ID: 25489992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics.
    Kang DD; Li H; Dong Y
    Adv Drug Deliv Rev; 2023 Aug; 199():114961. PubMed ID: 37321375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear reprogramming with a non-integrating human RNA virus.
    Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
    Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vitro Transcribed mRNA Vaccines with Programmable Stimulation of Innate Immunity.
    Loomis KH; Lindsay KE; Zurla C; Bhosle SM; Vanover DA; Blanchard EL; Kirschman JL; Bellamkonda RV; Santangelo PJ
    Bioconjug Chem; 2018 Sep; 29(9):3072-3083. PubMed ID: 30067354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Programming human dendritic cells with mRNA.
    Lee J; Boczkowski D; Nair S
    Methods Mol Biol; 2013; 969():111-25. PubMed ID: 23296931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immuno-engineered mRNA combined with cell adhesive niche for synergistic modulation of the MSC secretome.
    Drzeniek NM; Kahwaji N; Schlickeiser S; Reinke P; Geißler S; Volk HD; Gossen M
    Biomaterials; 2023 Mar; 294():121971. PubMed ID: 36634491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-efficiency cellular reprogramming with microfluidics.
    Luni C; Giulitti S; Serena E; Ferrari L; Zambon A; Gagliano O; Giobbe GG; Michielin F; Knöbel S; Bosio A; Elvassore N
    Nat Methods; 2016 May; 13(5):446-52. PubMed ID: 27088312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic mRNAs Containing Minimalistic Untranslated Regions Are Highly Functional In Vitro and In Vivo.
    Mamaghani S; Penna RR; Frei J; Wyss C; Mellett M; Look T; Weiss T; Guenova E; Kündig TM; Lauchli S; Pascolo S
    Cells; 2024 Jul; 13(15):. PubMed ID: 39120273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concise review: induced pluripotency by defined factors: prey of oxidative stress.
    Qi S; Fang Z; Wang D; Menendez P; Yao K; Ji J
    Stem Cells; 2015 May; 33(5):1371-6. PubMed ID: 25594616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient mRNA delivery with graphene oxide-polyethylenimine for generation of footprint-free human induced pluripotent stem cells.
    Choi HY; Lee TJ; Yang GM; Oh J; Won J; Han J; Jeong GJ; Kim J; Kim JH; Kim BS; Cho SG
    J Control Release; 2016 Aug; 235():222-235. PubMed ID: 27266364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.